ArQule Inc. | Key People and Executives
Paolo Pucci
Chief Executive Officer & Director
Patrick J. Zenner
Chairman
Ran Nussbaum
Independent Director
Timothy C. Barabe
Independent Director
Ronald M. Lindsay
Independent Director
William G. Messenger
Independent Director
Susan L. Kelley
Independent Director
Michael D. Loberg
Independent Director
Peter S. Lawrence
President & Chief Operating Officer
Paolo Pucci
Chief Executive Officer & Director
Robert J. Weiskopf
Chief Financial Officer & Treasurer
Brian D. Schwartz
Chief Medical Officer
Shirish Hirani
SVP-Program Management & Product Planning
Manish Tandon
Senior Director-Business Development
Marc Schegerin
SVP-Corporate Strategy, Communication & Finance
Dawn Schottlandt
VP-Investor Relations & Corporate Communications
Deb Wall
Senior Manager-Human Resources
Patrick J. Zenner
Chairman
Ran Nussbaum
Independent Director
Timothy C. Barabe
Independent Director
Ronald M. Lindsay
Independent Director
William G. Messenger
Independent Director
Susan L. Kelley
Independent Director
Michael D. Loberg
Independent Director
| Address |
One Wall Street
Burlington Massachusetts 01803
United States
|
|
Employees
|
- |
| Website |
http://www.arqule.com |
| Updated |
07/08/2019 |
| ArQule, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of targeted therapeutics to treat cancers and rare diseases. The company discovers, develops and commercializes novel small molecule drugs in areas of unmet need that will dramatically extend and improve the lives of its patients. Its proprietary pipeline includes ARQ 531, Derazantinib, Miransertib, ARQ 751, ARQ 761. |
